Search Results for: California Stem Cell Treatment Center

Liveyon made $21.6 million says DOJ; leader gets 3 years prison for stem cell activities

/ / 1 Comment
Liveyon

Back in late August, Liveyon leader John Kosolcharoen pleaded to federal charges on stem cells. What was Liveyon? Liveyon was a splashy umbilical cord stem cell supplier company. I don’t know if the company is still active now. One of its core products ended up sending dozens of people to the hospital due to contamination […]

Liveyon made $21.6 million says DOJ; leader gets 3 years prison for stem cell activities Read More »

Weekly reads: test-tube burgers, CRISPR for space travel, more tuft cells

/ / Leave a Comment
test-tube burger

I’ve written before about so-called test-tube burgers and bacon and other lab grown meat. Test-tube burgers Cells like muscle and fat progenitor cells are the basis for these products. Sometimes stem cells may come into play for such “test-tube burgers” as I generally call this type of lab meat. Cost seems to be a main

Weekly reads: test-tube burgers, CRISPR for space travel, more tuft cells Read More »

Liveyon leader John Kosolcharoen pleads to federal felony charges on stem cells

/ / 2 Comments
John Kosolcharoen, Liveyon

The stem cell clinic arena is a Wild West but perhaps few have been wilder than the perinatal stem cell clinic firm Liveyon run by John Kosolcharoen. Now John Kosolcharoen has pleaded guilty to felony charges related to Liveyon’s activities including distribution of an unapproved cell therapy drug. He will be sentenced next month. This

Liveyon leader John Kosolcharoen pleads to federal felony charges on stem cells Read More »

Recommended reads: private cord blood bank disappointments, Mammoth genomes, Huntington’s CRISPR, Parkinson’s cell therapy

/ / 2 Comments
umbilical-cord-blood, umbilical cord blood stem cells

The private cord blood bank industry has promised families all kinds of great things over the years. A typical ad for such cord blood banks might say, “Your child may need cord blood in the future for a cure.” The industry also often uses the analogy of frozen cord blood as an insurance policy for

Recommended reads: private cord blood bank disappointments, Mammoth genomes, Huntington’s CRISPR, Parkinson’s cell therapy Read More »

Lung Institute stem cell clinic loses class action suit, patients awarded $9M

/ / Leave a Comment
The-Lung-Institute

Remember the Lung Institute? Many patients raised red flags about their experiences there. It was also once known as the Lung Health Institute. More generally, patients who have been harmed by stem cell clinics have had to rely on other ways beyond the FDA to try to do something about it. The FDA has been

Lung Institute stem cell clinic loses class action suit, patients awarded $9M Read More »

9th Circuit hearing on FDA appeal of Cell Surgical Network case: maybe encouraging?

/ / 5 Comments
Cell Surgical Nework

I was able to watch some of the 9th Circuit Court hearing today on the FDA appeal of its loss in the Cell Surgical Network lawsuit. This post is my brief impressions as a scientist. What went down? Do the three judges seem to be leaning one way or another? The ruling in this case

9th Circuit hearing on FDA appeal of Cell Surgical Network case: maybe encouraging? Read More »

Weekly reads: late Macchiarini retractions, stem cells & Lululemon

/ / 8 Comments
Paolo-Macchiarini

Paolo Macchiarini is one of a small group of people in the stem cell universe whose misconduct has blown up in the press. Piero Anversa, Haruko Obokata, Hwang Woo-Suk, and some operators in the unproven stem cell clinic sphere come to mind. Macchiarini published quite a few seriously problematic papers, some of which just hung

Weekly reads: late Macchiarini retractions, stem cells & Lululemon Read More »

Weekly reads: stem cells for MS, Kimera Labs IND, FDA lawsuit

/ / 10 Comments
Symptoms_of_multiple_sclerosis

There has been a steady stream of encouraging data on stem cells for MS. Particularly for certain kinds of MS. A new study adds to this upbeat direction. Good news on stem cells for MS Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study, Journal of Neurology, Neurosurgery,

Weekly reads: stem cells for MS, Kimera Labs IND, FDA lawsuit Read More »

Goldwater Institute weighs in against FDA on Cell Surgical Network lawsuit appeal

/ / 6 Comments
Elliot Lander, Cell Surgical Network

An important appeals case is pending not just for the defendants Cell Surgical Network, et al., but also for the FDA. It could impact the stem cell field very broadly too. Cell Surgical Network lawsuit status Hopefully, we’ll get a decision before the end of this year. Cell Surgical Network is a large chain of

Goldwater Institute weighs in against FDA on Cell Surgical Network lawsuit appeal Read More »